Table 7. Forest plot on the rate of mother-to-child hepatitis B virus transmission (HBsAg seropositivity or HBV-DNA seropositivity).
| Study or Subgroup | Second Trimester | Third Trimester | Weight | Risk Ratio | Risk Ratio | ||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| Events | Total | Events | Total | M-H,Fixed,95% CI | M-H,Fixed,95% CI | ||
| 7.1 HBsAg seropositivity |
|
||||||
| 4.4.1 HBsAg seropositivity | |||||||
| Han et al.23 | 0 | 257 | 0 | 105 | Not estimable | ||
| Liu et al.22 | 0 | 24 | 2 | 32 | 21.6% | 0.26 [0.01, 5.26] | |
| Pan et al.25 | 0 | 66 | 0 | 94 | Not estimable | ||
| Wang et al.24 | 0 | 21 | 0 | 27 | Not estimable | ||
| Wang et al.21 (1) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.21 (2) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.21 (3) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.21 (4) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.21 (5) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.21 (6) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (1) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al. 18 (2) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (3) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (4) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (5) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (6) | 0 | 20 | 0 | 20 | Not estimable | ||
| Yin and Wang19 | 0 | 74 | 0 | 149 | Not estimable | ||
| Zhou et al.17 | 0 | 49 | 5 | 64 | 47.9% | 0.12 [0.01, 2.09] | |
| Subtotal (95% CI) | 731 | 711 | 69.5% | 0.16 [0.02, 1.28] | |||
| Total events | |||||||
| Heterogeneity: Chi2 = 0.15; df = 1 (P = 0.70); I2 = 0% | |||||||
| Test for overall effect: Z = 1.73 (P = 0.08) | |||||||
| 7.2 HBV DNA seropositivity | |||||||
| Han et al.23 | 0 | 257 | 0 | 105 | Not estimable | ||
| Liu et al.22 | 0 | 24 | 0 | 32 | Not estimable | ||
| Pan et al.25 | 0 | 66 | 0 | 94 | Not estimable | ||
| Wang et al.24 | 0 | 21 | 0 | 27 | Not estimable | ||
| Wang et al.21 (1) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.21 (2) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.21 (3) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.21 (4) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.21 (5) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.21 (6) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (1) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (2) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (3) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (4) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (5) | 0 | 20 | 0 | 20 | Not estimable | ||
| Wang et al.18 (6) | 0 | 20 | 0 | 20 | Not estimable | ||
| Zhou et al.17 | 0 | 49 | 3 | 64 | 30.5% | 0.19 [0.01, 3.51] | |
| Subtotal (95% CI) | 657 | 562 | 30.5% | 0.19 [0.01, 3.51] | |||
| Total events | 0 | 3 | |||||
| Heterogeneity: Not applicable | |||||||
| Test for overall effect: Z = 1.12 (P = 0.26) | |||||||
|
| |||||||
| Total (95% CI) | 1,388 | 1,273 | 100% | 0.17 [0.03, 0.92] | |||
|
| |||||||
| Total events | 0 | 10 | |||||
|
| |||||||
| Heterogeneity: Chi2 = 0.15; df = 2 (P = 0.93); I2 = 0% | |||||||
| Test for overall effect: Z = 2.06 (P = 0.04) | |||||||
| Test for subgroup differences: Chi2 = 0.00; df = 1 (P = 0.94) ; I2 = 0% | |||||||